glp-1 drugs sleep apnea Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Syndrome Management: A Narrative Review GLP-1 drugs and sleep apnea
Description
[7] The US Food and Drug Administration (FDA) approved dulaglutide with a Risk Evaluation and Mitigation Strategy (REMS), [7] and granted the approval of Trulicity to Eli Lilly and Company
By mimicking the bodys endogenous GLP-1, these drugs suppress appetite, slow gastric emptying, and influence reward mechanisms in the brain
)
Slowing Down Digestion: These injections activate receptors in the stomach to slow the digestion process, which helps in better nutrient absorption and reduces post-meal glucose spikes, contributing to gradual blood sugar levels and aiding in weight management
It is not entirely clear whether GLP-1RAs have direct effects on tumor cells, or if the benefits seen in animal models are entirely due to the indirect effect of decreased food intake
While successful, use of the patient assistance program is not a viable solution for everyone
